Cargando…

Activated Partial Thromboplastin Time or Prothrombin Time Prolongation During Rivaroxaban Administration: Clinical Risk Factors and Outcomes Analysis

Activated partial thromboplastin time (aPTT) or prothrombin time (PT) is often detected after rivaroxaban administration, and it is known that aPTT or PT can be prolonged or normal. However, the clinical risk factors and outcomes of prolongation were unknown. In a single-center, retrospective case-c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Yao, Li, Xinyu, Qiu, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Manuscript
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272684/ https://www.ncbi.nlm.nih.gov/pubmed/37271988 http://dx.doi.org/10.1177/10760296231178546

Ejemplares similares

The Effect of Sugammadex on Prothrombin and Activated Partial Thromboplastin Time
por: Samara, Evangelia, et al.
Publicado: (2021)

Genetic Polymorphisms Associated with Prothrombin Time and Activated Partial Thromboplastin Time in Chinese Healthy Population
por: Zhang, Fan, et al.
Publicado: (2022)

Risk stratification and prognostic value of prothrombin time and activated partial thromboplastin time among COVID-19 patients
por: Tekle, Esayas, et al.
Publicado: (2022)

The Prognostic Role of Prothrombin Time and Activated Partial Thromboplastin Time in Patients with Newly Diagnosed Multiple Myeloma
por: Geng, Chuanying, et al.
Publicado: (2021)

Role of thromboelastography in the evaluation of septic shock patients with normal prothrombin time and activated partial thromboplastin time
por: Kim, Sang-Min, et al.
Publicado: (2021)

Isolated Prolongation of Activated Partial Thromboplastin Time: Not Just Bleeding Risk!
por: Santoro, Rita Carlotta, et al.
Publicado: (2023)

Effect of storage conditions on prothrombin time, activated partial thromboplastin time and fibrinogen concentration on canine plasma samples
por: Piccione, Giuseppe, et al.
Publicado: (2010)

The effects of hemolysis on plasma prothrombin time and activated partial thromboplastin time tests using photo-optical method
por: Hernaningsih, Yetti, et al.
Publicado: (2017)

Prediction of Poor Outcomes in Patients with Colorectal Cancer: Elevated Preoperative Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT)
por: Zhang, Lin, et al.
Publicado: (2020)

Caution in Using the Activated Partial Thromboplastin Time to Monitor Argatroban in COVID-19 and Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT)
por: Guy, Susan, et al.
Publicado: (2021)

Prothrombin Time and Activated Partial Thromboplastin Time Testing: A Comparative Effectiveness Study in a Million-Patient Sample
por: Capoor, Manu N., et al.
Publicado: (2015)

Evaluation of Prothrombin Time and Activated Partial Thromboplastin Time in Hypertensive Patients Attending a Tertiary Hospital in Calabar, Nigeria
por: Nnenna Adaeze, Nnamani, et al.
Publicado: (2014)

Assessment of Stability of Prothrombin Time, International Normalized Ratio, and Activated Partial Thromboplastin Time Under Different Storage Conditions in Human Plasma
por: Patil, Parag, et al.
Publicado: (2022)

Sequential thrombosis and bleeding in a woman with a prolonged activated partial thromboplastin time
por: Spencer, Akpan, et al.
Publicado: (2011)

Falsely prolonged activated partial thromboplastin time – a pre- and post-analytical issue
por: Gils, Charlotte, et al.
Publicado: (2018)

FRACTIONATION OF PLASMA GLOBULIN FOR PROTHROMBIN, THROMBOKINASE, AND ACCESSORY THROMBOPLASTIN
por: Milstone, J. H.
Publicado: (1951)

Prothrombin Time and Coagulation Factor IX as Hemostatic Risk Markers for Legg– Calvé–Perthes Disease
por: Hernández-Zamora, Edgar, et al.
Publicado: (2023)

A case of syphilis presenting with prolonged etiology‐unrevealed fever, accompanying activated partial thromboplastin time prolongation
por: Yasuo, Kazuhiro
Publicado: (2018)

Standardization of Coagulation Factor V Reference Intervals, Prothrombin Time, and Activated Partial Thromboplastin Time in Mice for Use in Factor V Deficiency Pathological Models
por: De Pablo-Moreno, Juan A., et al.
Publicado: (2022)

A Patient with a Prolonged Activated Partial Thromboplastin Time and a Deep Intracerebral Haemorrhage
por: Schindhelm, Roger K., et al.
Publicado: (2012)

Prolonged activated partial thromboplastin time secondary to factor XII deficiency in two surgical patients
por: Moiz, Bushra, et al.
Publicado: (2021)

Andexanet Alfa Versus Prothrombin Complex Concentrates/Blood Products as Apixaban/Rivaroxaban Reversal Agents: A Survey Among Pediatric Hematologists
por: Rodriguez, Vilmarie, et al.
Publicado: (2022)

Diagnostic and Prognostic Significance of the Prothrombin Time/International Normalized Ratio in Sepsis and Septic Shock
por: Schupp, Tobias, et al.
Publicado: (2022)

Effect of the reaction temperature on the prothrombin time and the apparent International Normalized Ratio determined with International Standards for thromboplastins
por: Van Den Besselaar, Antonius M. H. P., et al.
Publicado: (2021)

Therapeutic monitoring of rivaroxaban in dogs using thromboelastography and prothrombin time
por: Bae, Junwoo, et al.
Publicado: (2019)

International normalized ratio and activated partial thromboplastin time testing
por: Chornenki, Nicholas L. J., et al.
Publicado: (2022)

Factors That Determine the Prothrombin Time in Patients With Atrial Fibrillation Receiving Rivaroxaban
por: Huang, Jen-Hung, et al.
Publicado: (2018)

A Rare Cause of Isolated Prolonged Activated Partial Thromboplastin Time: An Overview of Prekallikrein Deficiency and the Contact System
por: Riano, Ivy, et al.
Publicado: (2021)

A Patient with Severe Fever with Thrombocytopenia Syndrome, Activated Partial Thromboplastin Time Prolongation, and Transient Antiphospholipid Antibodies
por: Tsukamoto, Yutaka, et al.
Publicado: (2022)

Prothrombin Time, Activated Partial Thromboplastin Time, and Fibrinogen Reference Intervals for Inbred Strain 13/N Guinea Pigs (Cavia porcellus) and Validation of Low Volume Sample Analysis
por: Condrey, Jillian A., et al.
Publicado: (2020)

Comparative analysis on characteristics of two activated partial thromboplastin time reagents
por: Yasui, Yutaro, et al.
Publicado: (2022)

Whole-blood Point-of-Care Activated Partial Thromboplastin Time Ratio (APR) is not Accurate Enough to Monitor Heparin Therapy in Patients with Severe Respiratory Failure Secondary to SARS-Cov-2 Infection Supported with Veno-Venous Extracorporeal Membrane Oxygenation (VV-ECMO)
por: Aston, Daniel, et al.
Publicado: (2022)

Prothrombin Time-International Normalized Ratio Predicts the Outcome of Atrial Fibrillation Patients Taking Rivaroxaban
por: Chao, Tze-Fan, et al.
Publicado: (2022)

Prognostic Values of Prothrombin Time and Inflammation-Related Parameter in Acute Ischemic Stroke Patients After Intravenous Thrombolysis with rt-PA
por: Zhao, Jingru, et al.
Publicado: (2023)

Prolonged activated partial thromboplastin time predicts poor short‐term prognosis in patients with acute pancreatitis: A retrospective cohort study
por: Yang, Yuping, et al.
Publicado: (2022)

Prolonged Grief in Times of Lockdown During the COVID-19 Pandemic
por: von Blanckenburg, Pia, et al.
Publicado: (2023)

Activated Partial Thromboplastin Time and Mortality in Coronary Artery Bypass Grafting Patients
por: Zhang, HuanRui, et al.
Publicado: (2022)

Isolated prolongation of activated partial thromboplastin time in intensive care unit patients: a practical diagnostic algorithm and management options
por: Czempik, Piotr F., et al.
Publicado: (2020)

Enhancing the Quality of Rivaroxaban Exposure Estimates Using Prothrombin Time in the Absence of Pharmacokinetic Sampling
por: Solms, Alexander, et al.
Publicado: (2019)

A Comparison of Activated Partial Thromboplastin Time and Activated Coagulation Time for Anticoagulation Monitoring during Extracorporeal Membrane Oxygenation Therapy
por: Liu, Ying, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pqgjjh77qj5ktihu4o1ubs30sd